Amanda F. Cashen, MD, associate professor of medicine at Washington University School of Medicine in St. Louis, has been named executive chair of the university’s Institutional Review Board, the multidisciplinary group that reviews and approves protocols for research studies that involve human subjects. The group is responsible for protecting the rights and welfare of anyone participating in a research study conducted by Washington University investigators.
Cashen began her new role May 1. She will serve a four-year renewable term.
“We are delighted Dr. Cashen will be serving in this role,” said Jennifer K. Lodge, the university’s vice chancellor for research and a professor of molecular microbiology at the School of Medicine. “She has extensive experience in conducting clinical trials of novel therapies for leukemias and lymphomas and has enrolled hundreds of patients in such trials over the past 20 years.”
Read more on the School of Medicine site.
Comments and respectful dialogue are encouraged, but content will be moderated. Please, no personal attacks, obscenity or profanity, selling of commercial products, or endorsements of political candidates or positions. We reserve the right to remove any inappropriate comments. We also cannot address individual medical concerns or provide medical advice in this forum.